Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Zydus Lifesciences Ltd

ZYDUSLIFE.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Large Cap Analyst: HOLD

Last Close

$11.89

▼ -2.75%

Market Cap $11.86B · Vol 804.34K

Key Metrics

P/E Ratio

25.30

FWD: 25.54

Market Cap

$11.86B

Large Cap

Div Yield

0.09%

Annual dividend

EPS Growth

-24.24%

YoY

RSI (14)

55.29

Momentum

Beta

0.64

vs Market

52W High

$12.63

5.90% below

52W Low

$8.75

32.33% above

Volume

804.34K

Avg 1.49M

P/B

3.23

Price-to-book

ROE

21.76%

Return on equity

Free Float

24.82%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Zydus Lifesciences Ltd (ZYDUSLIFE.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ZYDUSLIFE.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+1.88%

+0.14%

+14.47%

+25.48%

YTD

+24.15%

+14.81%

+54.17%

+103.28%

Financials & Valuation

TTM · Annual

Total Revenue	$2.90B
Net Income	$537.83M
Revenue Growth (YoY)	+21.96%
Gross Margin	63.91%
Operating Margin	21.31%
Net Profit Margin	18.87%
ROE	21.76%
ROA · ROIC	14.78% · 14.84%

P/E Ratio	25.30
Forward P/E (FY1)	25.54
PEG Ratio	1.53
P/S	3.23
P/B	3.23
P/FCF	N/A
EPS Growth	-24.24%
Outstanding Shares	997.50M

Technical Indicators

50-Day SMA	$11.75
200-Day SMA	$10.25
RSI (14)	55.29
Beta	0.64
52-Week High	$12.63
52-Week Low	$8.75

Volume Today	804.34K
Avg Daily Volume (30D)	1.49M
Relative Volume	0.54x
Volatility (10D)	39.21
Volatility (30D)	26.22
Free Float	24.82%

Analyst Consensus

HOLD

Current Price $11.89

Mean Target $12.62

52W Low$8.75 52W High$12.63

Current

Target

$8.75 $12.63

Current Analyst target

+6.14% upside potential · 31 analysts

Identifiers

ExchangeNSE India

FIGIBBG001SF7KP4

ISININE010B01027

CountryIndia

Sub-IndustryGeneric Pharmaceuticals

Earnings DateNov 9, 2026

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

SUNPHARMA.NS Sun Pharmaceutical Industries Ltd -0.10% 4578.T Otsuka Holdings Co Ltd -3.26% CIPLA.NS Cipla Ltd -0.60% RICHTER.BU Richter Gedeon Vegyeszeti Gyar Nyrt +1.56% 4528.T Ono Pharmaceutical Co Ltd +0.52%

Company Profile

Zydus Lifesciences Limited is an India-based life-sciences company with positions across pharmaceuticals and consumer wellness, supported by a MedTech franchise and a global footprint across United States, India and other international markets. Its pharmaceutical business includes integrated pharmaceutical operations with business encompassing the entire value chain in research, development, production, marketing and distribution of pharmaceutical products. Its product portfolio includes active pharmaceutical ingredients, human formulations, and animal health and veterinary. Its consumer products business includes development, production, marketing and distribution of differentiated health and wellness products. It provides biologicals manufacturing sites offering contract development and manufacturing organization services to biopharmaceutical companies globally. Its focused therapy areas include cardiology, anti-diabetes, super specialty areas of oncology and nephrology, and others.